To assess variable KRAS dependency across a panel of KRAS mutant human cancer cell lines, Ras dependency indexes (RDIs) were proposed and measured experimentally to examine cancer cell addiction to oncogenic KRAS in a quantitative manner7. The gene discussed is KRAS; the disease is cancer.